Organogenesis Holdings Inc
NASDAQ:ORGO
Organogenesis Holdings Inc?
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.42
6.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Organogenesis Holdings Inc
What unique competitive advantages
does Organogenesis Holdings Inc hold over its rivals?
What risks and challenges
does Organogenesis Holdings Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Organogenesis Holdings Inc.
Provide an overview of the primary business activities
of Organogenesis Holdings Inc.
What unique competitive advantages
does Organogenesis Holdings Inc hold over its rivals?
What risks and challenges
does Organogenesis Holdings Inc face in the near future?
Has there been any significant insider trading activity
in Organogenesis Holdings Inc recently?
Summarize the latest earnings call
of Organogenesis Holdings Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Organogenesis Holdings Inc.
Provide P/S
for Organogenesis Holdings Inc.
Provide P/E
for Organogenesis Holdings Inc.
Provide P/OCF
for Organogenesis Holdings Inc.
Provide P/FCFE
for Organogenesis Holdings Inc.
Provide P/B
for Organogenesis Holdings Inc.
Provide EV/S
for Organogenesis Holdings Inc.
Provide EV/GP
for Organogenesis Holdings Inc.
Provide EV/EBITDA
for Organogenesis Holdings Inc.
Provide EV/EBIT
for Organogenesis Holdings Inc.
Provide EV/OCF
for Organogenesis Holdings Inc.
Provide EV/FCFF
for Organogenesis Holdings Inc.
Provide EV/IC
for Organogenesis Holdings Inc.
Show me price targets
for Organogenesis Holdings Inc made by professional analysts.
What are the Revenue projections
for Organogenesis Holdings Inc?
How accurate were the past Revenue estimates
for Organogenesis Holdings Inc?
What are the Net Income projections
for Organogenesis Holdings Inc?
How accurate were the past Net Income estimates
for Organogenesis Holdings Inc?
What are the EPS projections
for Organogenesis Holdings Inc?
How accurate were the past EPS estimates
for Organogenesis Holdings Inc?
What are the EBIT projections
for Organogenesis Holdings Inc?
How accurate were the past EBIT estimates
for Organogenesis Holdings Inc?
Compare the revenue forecasts
for Organogenesis Holdings Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Organogenesis Holdings Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Organogenesis Holdings Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Organogenesis Holdings Inc compared to its peers.
Compare the P/E ratios
of Organogenesis Holdings Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Organogenesis Holdings Inc with its peers.
Analyze the financial leverage
of Organogenesis Holdings Inc compared to its main competitors.
Show all profitability ratios
for Organogenesis Holdings Inc.
Provide ROE
for Organogenesis Holdings Inc.
Provide ROA
for Organogenesis Holdings Inc.
Provide ROIC
for Organogenesis Holdings Inc.
Provide ROCE
for Organogenesis Holdings Inc.
Provide Gross Margin
for Organogenesis Holdings Inc.
Provide Operating Margin
for Organogenesis Holdings Inc.
Provide Net Margin
for Organogenesis Holdings Inc.
Provide FCF Margin
for Organogenesis Holdings Inc.
Show all solvency ratios
for Organogenesis Holdings Inc.
Provide D/E Ratio
for Organogenesis Holdings Inc.
Provide D/A Ratio
for Organogenesis Holdings Inc.
Provide Interest Coverage Ratio
for Organogenesis Holdings Inc.
Provide Altman Z-Score Ratio
for Organogenesis Holdings Inc.
Provide Quick Ratio
for Organogenesis Holdings Inc.
Provide Current Ratio
for Organogenesis Holdings Inc.
Provide Cash Ratio
for Organogenesis Holdings Inc.
What is the historical Revenue growth
over the last 5 years for Organogenesis Holdings Inc?
What is the historical Net Income growth
over the last 5 years for Organogenesis Holdings Inc?
What is the current Free Cash Flow
of Organogenesis Holdings Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Organogenesis Holdings Inc.
We don't have any information about ORGO's stock splits.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
May 8, 2025
|
|
88 Energy Ltd
ASX:88EDA
|
1-for-25
/25
|
0.001 0.025 AUD | 0.025 0.025 AUD |
|
May 6, 2025
|
F
|
Future Bright Mining Holdings Ltd
HKEX:2957
|
1-for-40
/40
|
1.3 1.3 HKD | 1.3 1.3 HKD |
|
May 6, 2025
|
|
Sharplink Gaming Ltd
NASDAQ:SBET
|
1-for-12
/12
|
0.41 4.92 USD | 3.84 3.84 USD |
|
May 6, 2025
|
V
|
Villa Kunalai PCL
SET:KUN
|
26-for-25
x1.04
|
1.19 1.1347 THB | 1.2 1.2 THB |
|
May 6, 2025
|
Z
|
ZheJiang Yayi Metal Technology Co Ltd
SZSE:301113
|
1-for-1
x1
|
25.0201 18.7708 CNY | 20.24 20.24 CNY |
88EDA
SBET
Organogenesis Holdings Inc
Glance View
Organogenesis Holdings, Inc. is a regenerative medical company. The company is headquartered in Canton, Massachusetts and currently employs 950 full-time employees. The company went IPO on 2016-12-02. Its solutions address comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease, and smoking. The wound care products include Apligraf for the treatment of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs); Dermagraft for the treatment of diabetic foot ulcer (DFU); PuraPly AM and PuraPly XT as antimicrobial barriers for variety of wound types; and the Affinity and NuShield wound coverings to address a variety of wound sizes and types. Its surgical and sports medicine product includes ReNu for in-office knee osteoarthritis treatment; NuCel for bony fusion in the lumbar spine; NuShield and Affinity barrier products for surgical application in targeted soft tissue repairs; and PuraPly AM for management of open wounds in the surgical setting.
You don't have any saved screeners yet